Kestra Medical Technologies (KMTS) shares were up about 31% in recent trading following its Nasdaq debut Thursday after the company priced its initial public offering of about 11.9 million shares at $17 apiece.
Meanwhile, LendingTree (TREE) reported forecast-beating Q4 adjusted earnings and revenue in the previous day.
Its shares advanced 21% as intraday trading volume rose to over 1 million shares from a daily average of roughly 233,000.
Separately, Plus Therapeutics (PSTV) shares more than doubled after the US Food and Drug Administration granted its Rhenium Obisbemeda radiotherapy an orphan drug designation to treat leptomeningeal metastases in lung cancer patients.
More than 236 million shares traded intraday, compared with a daily average of about 176,000.
Price: 22.28, Change: +5.28, Percent Change: +31.03
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。